Literature DB >> 1062459

Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age, sex, and race of patients.

S O Krolls, S Hoffman.   

Abstract

Squamous cell carcinoma is the most frequently occurring malignant tumor of the oral structures, accounting for about 90% of the total number of malignant oral lesions. Among 14,253 cases of soft tissue squamous cell carcinomas of the oral area in the files of the Armed Forces Institute of Pathology, the most common locations are the lower lip (38% of the cases) and the tongue (21%). In the past few years, however, the number of carcinomas of the floor of mouth has been increasing. Our material also shows a definite trend of the carcinomas to develop in patients of an age group 10 years younger than has been previously reported.

Entities:  

Mesh:

Year:  1976        PMID: 1062459     DOI: 10.14219/jada.archive.1976.0556

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  18 in total

1.  [Oral squamous cell carcinoma Retrospective analysis of therapy results and prognosis by neoadjuvant, preoperative radio-chemotherapy].

Authors:  T Reuther; N K Posselt; J Rabbels; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2006-01

2.  Oral tumours.

Authors:  D R Lecavalier; J H Main
Journal:  Can Fam Physician       Date:  1988-06       Impact factor: 3.275

3.  Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers.

Authors:  Richard J Cassidy; Jeffrey M Switchenko; Naresh Jegadeesh; Mutlay Sayan; Matthew J Ferris; Bree R Eaton; Kristin A Higgins; Jeffrey T Wadsworth; Kelly R Magliocca; Nabil F Saba; Jonathan J Beitler
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-04-01       Impact factor: 6.223

4.  Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.

Authors:  Gefter Thiago Batista Correa; Vanessa Fátima Bernardes; Silvia Ferreira de Sousa; Marina Gonçalves Diniz; José Maria Porcaro Salles; Renan Pedra Souza; Alfredo Maurício Batista De-Paula; Ricardo Santiago Gomez; Carolina Cavalieri Gomes
Journal:  Tumour Biol       Date:  2015-06-18

5.  Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma.

Authors:  Kazuya Haraguchi; Manabu Habu; Naomi Yada; Masaaki Sasaguri; Izumi Yoshioka; Kazuhiro Tominaga
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

6.  Squamous cell carcinoma: morphological & topographical spectrum: a two year analysis.

Authors:  Sanjeev Narang; Namrata Kanungo; Ravi Jain
Journal:  Indian J Surg       Date:  2012-07-04       Impact factor: 0.656

7.  The impact factors on 5-year survival rate in patients operated with oral cancer.

Authors:  Dong-Ho Geum; Young-Chea Roh; Sang-Yong Yoon; Hyo-Geon Kim; Jung-Han Lee; Jae-Min Song; Jae-Yeol Lee; Dae-Seok Hwang; Yong-Deok Kim; Sang-Hun Shin; In-Kyo Chung; Uk-Kyu Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-10-22

8.  Controlling distant metastasis and surgical treatment are crucial for improving clinical outcome in uncommon head and neck malignancies, such as non-squamous cell carcinoma.

Authors:  Masashi Shiiba; Motoharu Unozawa; Morihiro Higo; Yukinao Kouzu; Atsushi Kasamatsu; Yosuke Sakamoto; Katsunori Ogawara; Katsuhiro Uzawa; Yuichi Takiguchi; Hideki Tanzawa
Journal:  Mol Clin Oncol       Date:  2014-05-08

9.  Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Eliene-Magda de-Assis; Luiz-Gustavo-Garcia-Santos Pimenta; Edson Costa-e-Silva; Paulo-Eduardo-Alencar Souza; Martinho-Campolina-Rebello Horta
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-09-01

10.  Deletion polymorphism at chromosome 3q26.1 and oral squamous cell carcinoma.

Authors:  Homare Kawachi; Keisuke Sugahara; Yasutaka Nakamura; Akira Katakura; Kiyoshi Minaguchi; Takahiko Shibahara
Journal:  Int J Oncol       Date:  2012-12-21       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.